Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical industries in the Swiss canton of Ticino, explains how a region with a population of 350,000 has managed to create a turnover of over two billion dollars, excelling as an innovative hub. Furthermore, he analyzes the response to the COVID-19 pandemic and the region’s ambitious plan for the future, including the creation of a technological pharmaceutical centre.
I predict that we will observe [pharma] manufacturing coming back to Europe, and Ticino will play a role in that
